1. Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia
- Author
-
Cristina Napoli, Ruben Manuel Luciano Colunga Biancatelli, Vincenzo Petrozza, Teresa Massaro, Marco Ciacciarelli, Luigi Iuliano, Umberto Ceratti, Gianluca Caruso, Piero Maceroni, Carmen Misurale, Andrea Lorusso, Veronica Sorrentino, Alberto Lombardini, Romina Milanese, Marco Rengo, Eleonora D'Armiento, Alessandro Polidoro, Sonia Ferri, and Leonardo Calvosa
- Subjects
medicine.medical_specialty ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Case Report ,030209 endocrinology & metabolism ,Diaphoresis ,Gastroenterology ,Diseases of the endocrine glands. Clinical endocrinology ,insulinoma ,MDCT ,03 medical and health sciences ,0302 clinical medicine ,Oliguria ,Edema ,Diabetes mellitus ,Internal medicine ,medicine ,Diazoxide ,Insulinoma ,business.industry ,Insulin ,Type 2 Diabetes Mellitus ,RC648-665 ,medicine.disease ,030220 oncology & carcinogenesis ,medicine.symptom ,business ,medicine.drug - Abstract
Insulinoma is an insulin-producing pancreatic neuroendocrine tumor that can be malignant in about 10% of cases. Locoregional invasion, lymph node metastases, or remote metastases are the main criteria of malignant insulinoma. Its incidence in patients with pre-existing diabetes mellitus (DM) is exceptionally rare. In this report, we describe a 66-year-old man with long-standing type 2 DM who presented with recurrent episodes of diaphoresis due to severe hypoglycemia despite the withdrawal of insulin therapy, hypercalcitoninemia, and biochemical and radiological findings suggestive of metastatic malignant insulinoma. Unfortunately, after few days of diazoxide treatment, edema, hypotension, oliguria, and water retention were observed, patient’s clinical status deteriorated rapidly, and he died in our department from acute renal failure.
- Published
- 2020